The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo

Journal of Medicinal Chemistry
L M GasterP D Slade

Abstract

5-HT1 receptors are members of the G-protein-coupled receptor superfamily and are negatively linked to adenylyl cyclase activity. The human 5-HT1B and 5-HT1D receptors (previously known as 5-HT1Dbeta and 5-HT1Dalpha, respectively), although encoded by two distinct genes, are structurally very similar. Pharmacologically, these two receptors have been differentiated using nonselective chemical tools such as ketanserin and ritanserin, but the absence of truly selective agents has meant that the precise function of the 5-HT1B and 5-HT1D receptors has not been defined. In this paper we describe how, using computational chemistry models as a guide, the nonselective 5-HT1B/5-HT1D receptor antagonist 4 was structurally modified to produce the selective 5-HT1B receptor inverse agonist 5, 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6, 7-tetrahydrospiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289). This compound is a potent antagonist of terminal 5-HT autoreceptor function both in vitro and in vivo.

References

Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R L WeinshankP R Hartig
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M RuatW Schunack
Jul 1, 1989·Journal of Medicinal Chemistry·P H ReggioS M Cox
Jul 1, 1994·Trends in Pharmacological Sciences·P Blier, C de Montigny
Dec 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·N AdhamT A Branchek
May 1, 1993·Medicinal Research Reviews·R M Pinder, J H Wieringa
Feb 1, 1996·Naunyn-Schmiedeberg's Archives of Pharmacology·M BühlenM Göthert
Jan 1, 1996·British Journal of Pharmacology·C RobertsB J Jones
Jun 13, 1996·European Journal of Pharmacology·K Kristiansen, S G Dahl
Oct 31, 1996·European Journal of Pharmacology·J M WatsonD N Middlemiss
Jul 23, 1997·European Journal of Pharmacology·J J HaganD N Middlemiss

❮ Previous
Next ❯

Citations

Aug 12, 1999·European Journal of Pharmacology·P De VriesP R Saxena
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·Daniel HoyerGraeme R Martin
Apr 27, 2001·Neuroscience and Biobehavioral Reviews·A Meneses
Jan 22, 2000·Neuroscience and Biobehavioral Reviews·A Meneses
Nov 9, 2002·Brain Research. Brain Research Reviews·Albert AdellFrancesc Artigas
Aug 6, 2000·British Journal of Pharmacology·C RoutledgeD N Middlemiss
Jun 24, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Alda M AmbrósioCarlos N Pato
Jul 13, 2000·Journal of Psychopharmacology·S HjorthS B Auerbach
Nov 17, 2012·Cephalalgia : an International Journal of Headache·Deepak K BhattJes Olesen
Jul 28, 2016·Organic & Biomolecular Chemistry·Adam J CloseJohn Spencer
May 11, 2016·Journal of Alzheimer's Disease : JAD·Walid TajeddinnDag Aarsland
Apr 9, 2005·Medicinal Research Reviews·Willem SoudijnAdriaan P Ijzerman
Aug 21, 2013·Journal of Neurochemistry·Gabriele LoersGurcharan Kaur
Feb 13, 2014·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators
Sep 13, 2003·The Journal of Pharmacology and Experimental Therapeutics·Petrus J Pauwels, Francis C Colpaert
Jan 29, 2005·British Journal of Pharmacology·Tania O SteanNeil Upton
Jan 15, 2004·Molecular Pharmacology·Terry Kenakin
May 21, 2010·The Journal of Pharmacology and Experimental Therapeutics·Erich H SchneiderRoland Seifert
Jun 12, 2020·Neuropharmacology·Trevor Sharp, Nicholas M Barnes
Apr 5, 2019·ACS Chemical Neuroscience·Yusha LiuJohn F Neumaier
Sep 5, 2003·Journal of Medicinal Chemistry·Theo A BerkhoutJason Witherington
Mar 19, 2002·Chemical Research in Toxicology·Deepak K DalvieJohn P O'Donnell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.